Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAINT: Rilpivirine in HIV-1 infected children and adolescents
NCT00799864Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jan 2011
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of rilpivirine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Janssen Pharmaceutical. Started Jan 2011; status: completed.
02
Drugs
rilpivirine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00799864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00799864.